top of page
LISTEN TO THE POD
EMAIL SUBSCRIBE
WATCH ON THE PEN
🏠 HOME
📰 GLP-1 NEWS
📺 LIVE SHOW
🌕 ABOUT
OTP BOOK
💉 SHED
More
Use tab to navigate through the menu items.
Log In
DECODING GLP-1
An On The Pen Book
GET THE BOOK!
All Posts
Compound Tirzepatide
Zepbound
Mounjaro
Wegovy
Ozempic
Future Obesity Medicine
Compound Semaglutide
Zepbound Savings Card
Advocacy
Tirzepatide
Semaglutide
Novo Nordisk
FDA
Eli Lilly
FDA
pharmacies
compounded glp-1
503A Pharmacies
emvidutide
Pemvidutide
Trials
Semaglutide
Mazdutide
Type 2 Diabetes
Opinion
Retatrutide
Medicare
Rybelsus
Amycretin
Trulicity
Log in / Sign up
The Week Obesity Medicine Shook: Generics, MASH, CV Claims, and Lilly’s Exit
Dave Knapp
Sep 18
2 min read
Wegovy Approved for MASH: Hope Against a Vile Disease
Dave Knapp
Sep 18
3 min read
GLP-1s and Alcohol? Altimmune Just Launched a Phase 2 Trial to Find Out
Dave Knapp
Aug 28
3 min read
Semaglutide Breakthrough: A Lifeline for Liver Disease Patients Battling MASH
Dave Knapp
Nov 19, 2024
3 min read
bottom of page